Post

Thanks for correcting! We found it difficult to evaluate the mass spec platforms themselves (e.g., Astral, timsTOF) but the services run on top of those platforms like Biognosys and Seer are well-documented and were easier to include.

Sorry for being a bit spicy with the OP, i opened the tool expecting a comparison of mass-spec platforms hence the shock. Plus I guess we mass spec people are a bit touchy when affinity methods are described as proteomics😅 but of course we aren’t the audience for your tool.

No worries at all! Affinity methods are getting most of the attention from orthogonal disciplines (I am partly responsible for this) and I'm hoping this tool directs the right people towards mass spec vendors - these will largely be non-MS scientists as you say.